DAVID, Jan, Petr CHRASTINA, Karolína PEŠKOVÁ, Viktor KOŽICH, David FRIEDECKÝ, Tomáš ADAM, Eva HLÍDKOVÁ, Hana VINOHRADSKÁ, Dana NOVOTNÁ, Monika HEDELOVÁ, Eva AL TAJI, Andrea HOLUBOVÁ, Veronika SKALICKÁ, Milan MACEK, Renata GAILLYOVÁ and Felix VOTAVA. EPIDEMIOLOGY OF RARE DISEASES DETECTED BY NEWBORN SCREENING IN THE CZECH REPUBLIC. Central European journal of public health. Praha: Česká lékařská společnost J.E. Purkyně, 2019, vol. 27, No 2, p. 153-159. ISSN 1210-7778. Available from: https://dx.doi.org/10.21101/cejph.a5441.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name EPIDEMIOLOGY OF RARE DISEASES DETECTED BY NEWBORN SCREENING IN THE CZECH REPUBLIC
Authors DAVID, Jan (203 Czech Republic), Petr CHRASTINA (203 Czech Republic), Karolína PEŠKOVÁ (203 Czech Republic), Viktor KOŽICH (203 Czech Republic), David FRIEDECKÝ (203 Czech Republic), Tomáš ADAM (203 Czech Republic), Eva HLÍDKOVÁ (203 Czech Republic), Hana VINOHRADSKÁ (203 Czech Republic, belonging to the institution), Dana NOVOTNÁ (203 Czech Republic, belonging to the institution), Monika HEDELOVÁ (203 Czech Republic), Eva AL TAJI (203 Czech Republic), Andrea HOLUBOVÁ (203 Czech Republic), Veronika SKALICKÁ (203 Czech Republic), Milan MACEK (203 Czech Republic), Renata GAILLYOVÁ (203 Czech Republic, belonging to the institution) and Felix VOTAVA (203 Czech Republic).
Edition Central European journal of public health, Praha, Česká lékařská společnost J.E. Purkyně, 2019, 1210-7778.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 0.653
RIV identification code RIV/00216224:14110/19:00110154
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.21101/cejph.a5441
UT WoS 000472898100012
Keywords in English rare disease; newborn screening; Czech Republic; public health; epidemiology; prevention
Tags 14110212, 14110317, 14110616, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 11/5/2020 09:30.
Abstract
Objectives: Presymptomatic detection of patients with rare diseases (RD), defined by a population frequency less than 1: 2,000, is the task of newborn screening (NBS). In the Czech Republic (CZ), currently eighteen RD are screened: phenylketonuria/hyperphenylalaninemia (PK U/HPA), congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), cystic fibrosis (CF), medium chain acyl-CoA dehydrogenase deficiency (MCADD), long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD), very long chain acyl-CoA dehydrogenase deficiency (VLCADD), carnitine palmitoyl transferase I and II deficiency (CPTID, CPTIID), carnitine-acylcarnitine translocase deficiency (CACTD), maple syrup urine disease (MSUD), glutaric aciduria type I (GA I), isovaleryl-CoAdehydrogenase deficiency (IVA), argininemia (ARG), citrullinemia (CIT), biotinidase deficiency (BTD), cystathionine beta-synthase-deficient homocystinuria (CBSD HCU), and methylenetetrahydrofolate reductase deficiency homocystinuria (MTHFRD HCU). The aim was to analyze the prevalence of RD screened by NBS in CZ. Methods: We examined the NBS programme in CZ from 1 January 2010 to 31 December 2017, which covered 888,891 neonates. Dried blood spots were primarily analyzed using fluorescence immuno-assay, tandem mass spectrometry and fluorimetry. Results: The overall prevalence of RD among the neonate cohort was 1: 1,043. Individually, 1:2,877 for CH, 1:5,521 for PKU/HPA, 1 :6,536 for CF (1:5,887 including false negative patients), 1:12,520 for CAH, 1:22,222 for MCADD, 1:80,808 for LCHADD, 1:177,778 for GA I, 1 : 177,778 for IVA, 1:222,223 for VLCADD, 1:296,297 for MSUD, 1:8,638 for BTD, and 1:181,396 for CBSD HCU. Conclusions: The observed prevalence of RD, based on NBS, corresponds to that expected, more precisely it was higher for BTD and lower for MSUD, IVA, CBSD HCU, MCADD and VLCADD. Early detection of rare diseases by means of NBS is an effective secondary prevention tool.
PrintDisplayed: 20/7/2024 12:20